Microbiota also shape glucose and lipid homeostasis: colon-derived SCFAs and other metabolites influence hepatic/adipose metabolism and insulin sensitivity; mechanistic and translational evidence includes (i) lean-donor FMT improving insulin sensitivity in metabolic syndrome patients, and (ii) Akkermansia muciniphila improving metabolic profiles [69,70]. The gene discussed is INS; the disease is metabolic syndrome.